Antiepileptic drugs are not independently associated with cognitive dysfunction

Area of Science:

• Neurology
• Clinical Neuropsychology
• Pharmacology

Background:

• Cognitive impairment is a common concern in epilepsy management.
• The independent effect of individual antiepileptic drugs (AEDs) on cognition requires further investigation.
• Understanding factors influencing cognitive function is crucial for optimizing patient care.

Purpose of the Study:

• To test the hypothesis that individual AEDs are not associated with cognitive impairment beyond other clinically relevant factors.
• To identify predictors of objective and subjective cognitive function in patients with epilepsy.
• To evaluate the impact of AEDs on cognitive function in an inpatient epilepsy monitoring setting.

Main Methods:

• Cross-sectional study of 331 patients admitted to an inpatient video-EEG monitoring unit (2009-2016).
• Comprehensive assessments included objective cognitive tests, quality of life scales for subjective cognition, and questionnaires for anxiety and depressive symptoms.
• Bayesian model averaging and selection were used to identify predictors of cognitive function and the effect of individual AEDs, with conventional frequentist analyses also performed.

Main Results:

• Age, seizure frequency, and comorbid psychogenic nonepileptic seizures predicted objective cognitive function.
• Depression, anxiety, and seizure frequency predicted subjective cognitive function.
• No individual AED was found to be independently associated with impaired cognitive function when controlling for other clinical variables.

Conclusions:

• Individual antiepileptic drugs (AEDs) are not independently linked to cognitive dysfunction in epilepsy patients.
• Seizure frequency and depression are significant determinants of cognitive impairment, both objectively and subjectively.
• Optimizing epilepsy therapy to control seizures is unlikely to negatively impact cognitive function.